Searchable abstracts of presentations at key conferences in endocrinology

ea0063p430 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Efficacy of DHEA in improving Quality of Life in prolonged HPA axis suppression from exogenous steroids

Anandappa Samantha , Kumar Rakshit , Breen Louise , Thakali Sonu , Tam Maria , Magtoto Cynthia , Carroll Paul , Velusamy Anand

Dehydroepiandrosterone (DHEA) has been a subject of controversy for more than a decade being called ‘a miracle hormone’, the ‘elixir of life’ and ‘an anti-aging supplement’. However, recent literature has proven mild to moderate benefit in selected group of patients. Data is mostly limited to primary adrenal failure patients with adequate glucocorticoid and mineralocorticoid replacement and in hypopituitarism from variable aetiology associated wit...